Mislocalization of the exitatory amino-acid transporters (EAATs) in human astrocytoma and non-astrocytoma cancer cells: Effect of the cell confluence

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Varini, Karine ^a   Benzaria, Amal ^b   Taïeb, Nadira ^b   Di Scala, Coralie ^b   Azmi, Amanda ^b   Graoudi, Soraya ^b   Maresca, Marc ^b  

^a University of Mediterranée   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Astrocytoma; Cancer; EAAT; GLAST; GLT 1; Glutamate; Mislocalization; STTG 1

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; ASTROCYTOMA CELL; CANCER CELL; CELL CONTACT; CELL FRACTIONATION; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; RAT; ASTROCYTE; ASTROCYTOMA; FLUORESCENCE MICROSCOPY; METABOLISM; NEOPLASM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM X-AG; AMINO ACID TRANSPORT SYSTEMS; ASTROCYTES; ASTROCYTOMA; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELL FRACTIONATION; CELL LINE, TUMOR; GLUTAMIC ACID; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASMS;

EID: 84856397599     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-10     Document Type: Article

References (25)

1. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Ohgaki H, Kleihues P, J Neuropathol Exp Neurol 2005 64 479 489 15977639 (Pubitemid 40781150)
2. Epidemiology and etiology of gliomas. Ohgaki H, Kleihues P, Acta Neuropathol 2005 109 93 108 10.1007/s00401-005-0991-y 15685439 (Pubitemid 40287792)
3. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Stewart LA, Lancet 2002 359 1011 1018 11937180 (Pubitemid 34286538)
4. Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. Noch E, Khalili K, Cancer Biol Ther 2009 8 1791 1797 19770591
5. Current and emerging molecular targets in glioma. Roesler R, Brunetto AT, Abujamra AL, de Farias CB, Brunetto AL, Schwartsmann G, Expert Rev Anticancer Ther 2010 10 1735 1751 10.1586/era.10.167 21080801
6. Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage. Sontheimer H, Trends Neurosci 2003 26 543 549 10.1016/j.tins.2003. 08.007 14522147 (Pubitemid 37176909)
7. A role for glutamate in growth and invasion of primary brain tumors. Sontheimer H, J Neurochem 2008 105 287 295 10.1111/j.1471-4159.2008.05301.x 18284616 (Pubitemid 351490026)
8. Hypoxia helps glioma to fight therapy. Amberger-Murphy V, Curr Cancer Drug Targets 2009 9 381 390 10.2174/156800909788166637 19442057
9. Insight into the complex regulation of CD133 in glioma. Campos B, Herold-Mende CC, Int J Cancer 2010 128 501 510
10. Notch signaling in glioblastoma: a developmental drug target? Lino MM, Merlo A, Boulay JL, BMC Med 2010 8 72 10.1186/1741-7015-8-72 21078177
11. On the origin and growth of gliomas. Schiffer D, Annovazzi L, Caldera V, Mellai M, Anticancer Res 2010 30 1977 1998 20651342
12. The astrocyte odyssey. Wang DD, Bordey A, Prog Neurobiol 2008 86 342 367 18948166
13. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. Ye ZC, Rothstein JD, Sontheimer H, J Neurosci 1999 19 10767 10777 10594060 (Pubitemid 30235723)
14. Autocrine glutamate signaling promotes glioma cell invasion. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H, Cancer Res 2007 67 9463 9471 10.1158/0008-5472.CAN-07-2034 17909056 (Pubitemid 47535936)
15. Inhibition of cystine uptake disrupts the growth of primary brain tumors. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY, Sontheimer H, J Neurosci 2005 25 7101 7110 10.1523/JNEUROSCI.5258-04.2005 16079392 (Pubitemid 41113926)
16. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Arcella A, Carpinelli G, Battaglia G, D'Onofrio M, Santoro F, Ngomba RT, Bruno V, Casolini P, Giangaspero F, Nicoletti F, Neuro Oncol 2005 7 236 245 10.1215/S1152851704000961 16053698 (Pubitemid 41079133)
17. Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells. D'Onofrio M, Arcella A, Bruno V, Ngomba RT, Battaglia G, Lombari V, Ragona G, Calogero A, Nicoletti F, J Neurochem 2003 84 1288 1295 10.1046/j.1471-4159.2003.01633.x 12614329 (Pubitemid 36343595)
18. EAAT1 is involved in transport of L-glutamate during differentiation of the Caco-2 cell line. Mordrelle A, Jullian E, Costa C, Cormet-Boyaka E, Benamouzig R, Tomé D, Huneau JF, Am J Physiol Gastrointest Liver Physiol 2000 279 366 373 10915646
19. Cancer cells release glutamate via the cystine/glutamate antiporter. Sharma MK, Seidlitz EP, Singh G, Biochem Biophys Res Commun 2010 391 91 95 10.1016/j.bbrc.2009.10.168 19896463
20. Characterization of a cell line derived from a human oligodendroglioma. Post GR, Dawson G, Mol Chem Neuropathol 1992 16 303 317 10.1007/BF03159976 1329795
21. The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1. Razafimanjato H, Garmy N, Guo XJ, Varini K, Di Scala C, Di Pasquale E, Taeb N, Maresca M, Neurotoxicology 2010 31 475 484 10.1016/j.neuro.2010.06.003 20558201
22. The ribotoxin deoxynivalenol affects the viability and functions of glial cells. Razafimanjato H, Benzaria A, Taeb N, Guo XJ, Vidal N, Di Scala C, Varini K, Maresca M, Glia 2011 59 1672 1683 10.1002/glia.21214 21748807
23. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Maresca M, Mahfoud R, Pfohl-Leszkowicz A, Fantini J, Toxicol Appl Pharmacol 2001 176 54 63 10.1006/taap.2001.9254 11578148 (Pubitemid 32977290)
24. Silencing of selected glutamate receptor subunits modulates cancer growth. Luksch H, Uckermann O, Stepulak A, Hendruschk S, Marzahn J, Bastian S, Staufner C, Temme A, Ikonomidou C, Anticancer Res 2011 31 3181 3192 21965725
25. Genetic pathways to primary and secondary glioblastoma. Ohgaki H, Kleihues P, Am J Pathol 2007 170 1445 1453 10.2353/ajpath.2007.070011 17456751 (Pubitemid 47339290)